SwRI advances safer manufacturing of nerve agent antidotes is drawing significant interest across the industry.
Southwest Research Institute (SwRI) continues to expand its unique drug synthesis capabilities and expertise to advance the scalable manufacturing of safer antidotes to combat exposure to organophosphorus nerve agents (OPNAs) and pesticides.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Source: Original →